Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
Status:
Completed
Trial end date:
2019-02-02
Target enrollment:
Participant gender:
Summary
In this prospective clinical study, the investigators compare the outcome and clinical course
of consecutive septic participants treated with intravenous vitamin C, hydrocortisone, and
thiamine (treatment group) with a control group treated in the investigators' ICU. The
primary outcome is hospital survival. A propensity score is generated to adjust the primary
outcome.There is 70 participants in each group.